DK2240487T3 - Triazolopyridaziner som para-inhibitorer, fremstilling og anvendelse heraf som lægemiddel - Google Patents

Triazolopyridaziner som para-inhibitorer, fremstilling og anvendelse heraf som lægemiddel

Info

Publication number: DK2240487T3
Authority: DK; Denmark
Prior art keywords: triazolopyridazines; para; inhibitors; drug; preparation
Prior art date: 2008-02-05

Application number

DK09708289.5T

Other languages

English (en)

Inventor

Uwe Heinelt

Volkmar Wehner

Matthias Herrmann

Bodo Scheiper

Karl Schoenafinger

Henning Steinhagen

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-02-05

Filing date

2009-01-23

Publication date

2012-04-02

2009-01-23 Application filed by Sanofi Sa filed Critical Sanofi Sa

2012-04-02 Application granted granted Critical

2012-04-02 Publication of DK2240487T3 publication Critical patent/DK2240487T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Obesity (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Oncology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK09708289.5T 2008-02-05 2009-01-23 Triazolopyridaziner som para-inhibitorer, fremstilling og anvendelse heraf som lægemiddel DK2240487T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08290112		2008-02-05
PCT/EP2009/000406 WO2009097970A1 (de)	2008-02-05	2009-01-23	Triazolopyridazine als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel

Publications (1)

Publication Number	Publication Date
DK2240487T3 true DK2240487T3 (da)	2012-04-02

Family

ID=39539711

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK09708289.5T DK2240487T3 (da)	2008-02-05	2009-01-23	Triazolopyridaziner som para-inhibitorer, fremstilling og anvendelse heraf som lægemiddel

Country Status (32)

Country	Link
US (2)	US8076336B2 (da)
EP (1)	EP2240487B1 (da)
JP (1)	JP5526040B2 (da)
KR (1)	KR20100114514A (da)
CN (1)	CN101981034B (da)
AR (1)	AR070410A1 (da)
AT (1)	ATE537172T1 (da)
AU (1)	AU2009211887B2 (da)
BR (1)	BRPI0907486A2 (da)
CA (1)	CA2713550C (da)
CL (1)	CL2009000236A1 (da)
CO (1)	CO6260083A2 (da)
CY (1)	CY1113228T1 (da)
DK (1)	DK2240487T3 (da)
ES (1)	ES2379447T3 (da)
HK (1)	HK1149011A1 (da)
HR (1)	HRP20120230T1 (da)
IL (1)	IL207205A0 (da)
MA (1)	MA32061B1 (da)
MX (1)	MX2010008490A (da)
MY (1)	MY152040A (da)
NZ (1)	NZ587141A (da)
PA (1)	PA8814801A1 (da)
PE (1)	PE20091455A1 (da)
PL (1)	PL2240487T3 (da)
PT (1)	PT2240487E (da)
RS (1)	RS52264B (da)
RU (1)	RU2499797C2 (da)
SI (1)	SI2240487T1 (da)
TW (1)	TW200946532A (da)
WO (1)	WO2009097970A1 (da)
ZA (1)	ZA201004467B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2009002842A (es) *	2006-09-18	2009-05-27	Vertex Pharma	Inhibidores heterociclicos de c-met y usos de los mismos.
PL2240486T3 (pl) *	2008-02-05	2016-02-29	Sanofi Sa	Sole triazoliowe jako inhibitory PAR1, ich wytwarzanie i zastosowanie jako lek
US8673890B2 (en)	2009-10-29	2014-03-18	Janssen Pharmaceutica Nv	2,3-dihydro-1H-isoindol-1-imine derivatives useful as thrombin PAR-1 receptor antagonist
WO2020254554A1 (en) *	2019-06-19	2020-12-24	Nmd Pharma A/S	Process for the preparation of clc-1 chloride channel inhibitors

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4578464A (en)	1983-11-22	1986-03-25	Merrell Dow Pharmaceuticals Inc.	6-Hydroxyalkylamino-8-methyl-1,2,4-triazolo-[4,3-b]pyridazine and related compounds
WO1996008496A1 (en) *	1994-09-16	1996-03-21	Takeda Chemical Industries, Ltd.	Triazolopyridazines process and intermediates for their preparation and their use as medicaments
US6063847A (en)	1997-11-25	2000-05-16	Schering Corporation	Thrombin receptor antagonists
US7488742B2 (en)	2000-06-15	2009-02-10	Schering Corporation	Thrombin receptor antagonists
JP4220249B2 (ja)	2001-04-19	2009-02-04	エーザイ・アール・アンド・ディー・マネジメント株式会社	サイクリックアミジン誘導体
EP1391452A4 (en)	2001-05-25	2005-10-26	Mochida Pharm Co Ltd	4-HYDROXPIPERIDIN DERIVATIVE ANALGETIC EFFECT
WO2003031442A1 (fr)	2001-10-05	2003-04-17	Takeda Chemical Industries, Ltd.	Composes heterocycliques, derives oxazole, procede permettant de les presenter et leur utilisation
PE20030808A1 (es)	2001-10-18	2003-09-22	Schering Corp	Derivados triciclicos heterociclicos como antagonistas receptores de trombina
ATE455774T1 (de)	2002-04-16	2010-02-15	Schering Corp	Trizyklische thrombinrezeptorantagonisten
WO2004078721A1 (ja)	2003-02-19	2004-09-16	Eisai Co., Ltd.	環状ベンズアミジン誘導体の製造方法
TW200531688A (en)	2004-03-05	2005-10-01	Hoffmann La Roche	Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
EP1813282A4 (en)	2004-11-09	2011-03-02	Eisai R&D Man Co Ltd	MEANS FOR THE TREATMENT OF ANGIOSPASM IN SUBARACHO-OAL BLOODING WITH THROMBIN RECEPTOR ANTAGONIST AS AN ACTIVE AGENT
NZ568807A (en) *	2005-12-21	2011-05-27	Janssen Pharmaceutica Nv	Triazolopyridazines as tyrosine kinase modulators
DE102006025318A1 (de) *	2006-05-31	2007-12-06	Bayer Healthcare Ag	Dihydro-pyrrolopyridin-, Dihydro-pyrrolopyridazin- und Dihydro-pyrrolopyrimidin-Derivate und ihre Verwendung
DE102006036023A1 (de) *	2006-08-02	2008-02-07	Sanofi-Aventis	Imino-imidazo-pyridinderivate mit antithrombotischer Aktivität
CA2713554C (en)	2008-02-05	2016-09-06	Sanofi-Aventis	Imidazopyridazines as par1 inhibitors, production thereof, and use as medicaments
SI2242740T1 (sl)	2008-02-05	2013-03-29	Sanofi	SF5-derivati kot PAR1 inhibitorji, njihova priprava in uporaba kot zdravila
PL2240486T3 (pl) *	2008-02-05	2016-02-29	Sanofi Sa	Sole triazoliowe jako inhibitory PAR1, ich wytwarzanie i zastosowanie jako lek
WO2009126624A1 (en)	2008-04-11	2009-10-15	Bristol-Myers Squibb Company	Triazolo compounds useful as dgat1 inhibitors
WO2009126861A2 (en)	2008-04-11	2009-10-15	Bristol-Myers Squibb Company	Triazolopyridine compounds useful as dgat1 inhibitors

2009
- 2009-01-23 MY MYPI20103226 patent/MY152040A/en unknown
- 2009-01-23 MX MX2010008490A patent/MX2010008490A/es active IP Right Grant
- 2009-01-23 JP JP2010545378A patent/JP5526040B2/ja not_active Expired - Fee Related
- 2009-01-23 CA CA2713550A patent/CA2713550C/en not_active Expired - Fee Related
- 2009-01-23 AU AU2009211887A patent/AU2009211887B2/en not_active Ceased
- 2009-01-23 WO PCT/EP2009/000406 patent/WO2009097970A1/de active Application Filing
- 2009-01-23 RS RS20120103A patent/RS52264B/en unknown
- 2009-01-23 EP EP09708289A patent/EP2240487B1/de active Active
- 2009-01-23 RU RU2010136957/04A patent/RU2499797C2/ru not_active IP Right Cessation
- 2009-01-23 CN CN2009801115086A patent/CN101981034B/zh not_active Expired - Fee Related
- 2009-01-23 SI SI200930192T patent/SI2240487T1/sl unknown
- 2009-01-23 BR BRPI0907486-4A patent/BRPI0907486A2/pt not_active IP Right Cessation
- 2009-01-23 ES ES09708289T patent/ES2379447T3/es active Active
- 2009-01-23 NZ NZ587141A patent/NZ587141A/en not_active IP Right Cessation
- 2009-01-23 PT PT09708289T patent/PT2240487E/pt unknown
- 2009-01-23 AT AT09708289T patent/ATE537172T1/de active
- 2009-01-23 DK DK09708289.5T patent/DK2240487T3/da active
- 2009-01-23 PL PL09708289T patent/PL2240487T3/pl unknown
- 2009-01-23 KR KR1020107017452A patent/KR20100114514A/ko not_active Application Discontinuation
- 2009-02-03 AR ARP090100348A patent/AR070410A1/es not_active Application Discontinuation
- 2009-02-03 TW TW098103334A patent/TW200946532A/zh unknown
- 2009-02-03 PA PA20098814801A patent/PA8814801A1/es unknown
- 2009-02-03 CL CL2009000236A patent/CL2009000236A1/es unknown
- 2009-02-03 PE PE2009000154A patent/PE20091455A1/es not_active Application Discontinuation
2010
- 2010-06-24 ZA ZA2010/04467A patent/ZA201004467B/en unknown
- 2010-07-25 IL IL207205A patent/IL207205A0/en unknown
- 2010-08-04 MA MA33059A patent/MA32061B1/fr unknown
- 2010-08-04 CO CO10095026A patent/CO6260083A2/es active IP Right Grant
- 2010-08-05 US US12/851,189 patent/US8076336B2/en not_active Expired - Fee Related
2011
- 2011-03-30 HK HK11103239.2A patent/HK1149011A1/xx not_active IP Right Cessation
- 2011-09-23 US US13/243,118 patent/US9079906B2/en not_active Expired - Fee Related
2012
- 2012-03-13 HR HR20120230T patent/HRP20120230T1/hr unknown
- 2012-03-14 CY CY20121100256T patent/CY1113228T1/el unknown

Also Published As

Publication number	Publication date
RU2499797C2 (ru)	2013-11-27
CN101981034A (zh)	2011-02-23
TW200946532A (en)	2009-11-16
ATE537172T1 (de)	2011-12-15
PE20091455A1 (es)	2009-10-22
EP2240487A1 (de)	2010-10-20
AU2009211887A1 (en)	2009-08-13
IL207205A0 (en)	2010-12-30
CL2009000236A1 (es)	2009-06-05
PL2240487T3 (pl)	2012-05-31
MA32061B1 (fr)	2011-02-01
HRP20120230T1 (hr)	2012-04-30
MX2010008490A (es)	2010-08-18
SI2240487T1 (sl)	2012-04-30
US20120010203A1 (en)	2012-01-12
KR20100114514A (ko)	2010-10-25
JP2011511016A (ja)	2011-04-07
US9079906B2 (en)	2015-07-14
US20110034451A1 (en)	2011-02-10
AU2009211887B2 (en)	2013-09-19
EP2240487B1 (de)	2011-12-14
HK1149011A1 (en)	2011-09-23
CA2713550A1 (en)	2009-08-13
BRPI0907486A2 (pt)	2015-07-14
MY152040A (en)	2014-08-15
AR070410A1 (es)	2010-04-07
RU2010136957A (ru)	2012-03-20
CY1113228T1 (el)	2016-04-13
CO6260083A2 (es)	2011-03-22
RS52264B (en)	2012-10-31
US8076336B2 (en)	2011-12-13
CA2713550C (en)	2016-06-14
CN101981034B (zh)	2013-08-14
ZA201004467B (en)	2011-09-28
NZ587141A (en)	2012-04-27
PA8814801A1 (es)	2009-09-17
WO2009097970A1 (de)	2009-08-13
ES2379447T3 (es)	2012-04-26
PT2240487E (pt)	2012-03-08
JP5526040B2 (ja)	2014-06-18

Publication	Publication Date	Title
DK2051975T3 (da)	2012-10-15	Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel.
NL300886I2 (nl)	2017-10-24	baricitinib, of een farmaceutisch aanvaardbaar zout daarvan
DK2240017T3 (da)	2019-06-17	Ketonlegemer og ketonlegemsestere som blodlipid-sænkende midler
NO2016016I1 (no)	2016-08-17	Lesinurad, eller et farmasøytisk akseptabelt salt derav
NO2021006I1 (no)	2021-02-15	Quofenix, delafloksacin
NO2015012I1 (no)	2015-05-04	Ombitasvir, eller et farmasøytisk akseptabelt salt derav
BRPI0907036A2 (pt)	2015-07-07	Conjunto de máscara para fornecer gás para um paciente, e, kit de conjunto de máscara para fornecer um gás para um paciente.
DK2129595T3 (da)	2011-04-18	Drikkevareingredienskapsel
BRPI0910503A2 (pt)	2015-09-29	compostos, composições farmacêuticas e respectivos usos.
BRPI0920521A2 (pt)	2018-01-16	combinação farmacêutica
BRPI1010768A2 (pt)	2016-11-01	composto, e, composição farmacêutica.
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
BRPI0909770A2 (pt)	2015-08-11	Vacina, e, kit
CR10571A (es)	2009-05-14	Vacuna virica recombinante
FR2936709B1 (fr)	2012-05-11	Comprimes alcoolo-resistants.
BRPI1009372A2 (pt)	2016-05-31	compostos, composição farmacêutica e respectivos usos
BRPI0807078A2 (pt)	2014-04-08	Composto, e, formulação farmacêutica
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
DK2350026T3 (da)	2014-09-15	Sulfoximinsubstituerede anilinopyrimidinderativer som cdk-inhibitorer, fremstilling og anvendelse heraf som lægemiddel
DK2125048T3 (da)	2014-10-13	Præparat
PL2379086T3 (pl)	2016-01-29	Preparat farmeceutyczny
DK2364975T3 (da)	2013-09-08	Nyt amidderivat og anvendelse deraf som medikament.
EP2023715A4 (en)	2009-11-18	Indoleamine-2,3-dioxygenase 2
BR112012000831A2 (pt)	2019-09-24	compostos, composições farmacêuticas e métodos relacionados